GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham ...

GlaxoSmithKline ( (GSK)) has realeased its Q3 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors. GlaxoSmithKline (GSK) is a global biopharmaceutical ...

BMI has predicted that naira will reach N1,993/$ by 2028, impacting Nigeria’s pharmaceutical industry’s ability to import ...

As on Nov 08, 2024, Glaxosmithkline Pharmaceuticals Ltd (GLAXO)’s share price on NSE is Rs 2561.15 What is the market cap of Glaxosmithkline Pharmaceuticals Ltd (GLAXO?) The current market ...

GlaxoSmithKline said its key brands held their market share and continued to stay in line with the respective category performance. GlaxoSmithKline Pharmaceuticals on October 29 reported a 16 ...

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology market and expanding its preventive healthcare through adult vaccines.

The artificial intelligence (AI) market has created some monster growth ... including GSK (formerly GlaxoSmithKline), Dolce & Gabbana, and the U.S. Department of Defense. It's also expanding ...

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

For further results highlights, click. GlaxoSmithKline Pharma continued to benefit from rising market share for its antibiotic Augmentin and respiratory drugs Nucala and Trelegy. Moreover ...

Fitch Solutions has predicted that the naira would slide to as low as N1,993 per dollar in 2028, severely impacting Nigeria’s ...

Nigerians are bracing for more economic weakness after the local currency ... However, the Nigerian naira is still not ...